Real People, Real Stories” seeks to share local stories of loved ones lost to substance-use disorder in an upcoming Brattleboro art show.

This week, we are reporting on some promising treatments for two of the deadliest drugs in America: opioids and alcohol. William Brangham sat down with one of the nation’s leading researchers who is ...

A new study of over 32,000 US Veterans has found that the longer people stay on medications for opioid use disorder ...

Americans may not say it aloud, but drug addiction has long been considered a moral failing. "Just say no," as Nancy Reagan famously declared during the crack-cocaine epidemic of the 80s. That ...

According to the Department of Drug and Alcohol Programs, children need simple ways to understand substance use disorder and ...

Much of the conversation around addiction swings between two worldviews. On one side is the belief that addiction is a brain ...

Reducing stimulant use was associated with significant improvement in measures of health and recovery among people with stimulant use disorder, even if they did not achieve total abstinence. This ...

Research suggests psilocybin-assisted therapy may lead to decreases in alcohol consumption among those with alcohol use disorder (AUD). Psilocybin is the psychoactive chemical from magic mushrooms.

Ozempic was first approved to treat type 2 diabetes in 2017, but it’s garnered most of its recognition in recent years as a weight-loss drug. Now, as more people are taking it and scientists are ...

A sweeping bill would fund the VA to examine ketamine, magic mushrooms and other hallucinogens for potential medical use for ...

This article was produced as a project for the USC Annenberg Center for Health Journalism’s 2023 National Fellowship. NASHVILLE, Tenn. — After he graduated, Derek Scott proudly hung his degree from ...

Editor's Note: The graphic at the end of this segment used imprecise terminology. The Legal Action Center survey referred to “substance use disorder.” This week, we are reporting on some promising ...